Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when WST files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsWest Pharmaceutical Services reports Q1 2026 earnings, furnishes results via 8-K
Filed April 23, 2026 · Period ending April 23, 2026 · ~1 min read
Key Changes
-
high
West Pharmaceutical announced first-quarter 2026 financial results through a press release dated April 23, 2026. Actual financial figures and performance metrics are contained in the attached exhibit rather than the 8-K body.
Item 2.02 verify on EDGAR → -
medium
The company made investor presentation materials available on its website and as an exhibit, providing additional context beyond the basic earnings release for the quarterly investor call.
Item 7.01 verify on EDGAR → -
low
The 8-K is being 'furnished' rather than 'filed' under standard practice for earnings releases, limiting legal liability and preventing automatic incorporation into other SEC filings.
Item 7.01 verify on EDGAR →
Summary
West Pharmaceutical Services disclosed its first-quarter 2026 financial results on April 23, 2026, following standard quarterly reporting procedures. The company issued a press release and made presentation materials available to investors through its website and SEC exhibits. This is a routine earnings announcement with no unusual procedural elements.
For retail investors, the key takeaway is that Q1 2026 results are now public, though the actual financial performance metrics are contained in the press release exhibit rather than summarized in the 8-K itself. The company followed typical disclosure practices by furnishing rather than filing the information, which is standard for earnings-related 8-Ks and carries no special significance.
Investors should review the attached press release and presentation materials for the actual financial results, guidance updates, and management commentary on quarterly performance. Watch for any subsequent analyst reactions or management discussion of trends that could affect full-year 2026 expectations.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On April 23, 2026, West Pharmaceutical Services, Inc. (the “Company”) issued a press release announcing its first-quarter 2026 financial results.
The company disclosed its first-quarter 2026 financial results through a press release. The 8-K filing itself does not contain the actual financial figures or performance metrics, which are referenced as being in the attached Exhibit 99.1 press release.
Event · Item 7.01 — Regulation FD Disclosure
West Pharmaceutical Services furnished Regulation FD disclosure materials and earnings presentation via 8-K, not deemed filed.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
The information set forth in “Item 2.02 Results of Operations and Financial Condition,” including the exhibit referred to therein, is incorporated herein by reference.
The company is furnishing information under Regulation FD (Fair Disclosure) by incorporating Item 2.02 materials. This is a routine disclosure mechanism to ensure all investors receive material information simultaneously, typically accompanying earnings releases.
Event · Item 9.01 — Financial Statements and Exhibits
Item 9.01 — Financial Statements and Exhibits filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · view on EDGAR →
99.1
West Pharmaceutical Services, Inc. Press Release, dated April 23, 2026.
99.2
West Pharmaceutical Services, Inc. Presentation, dated April 23, 2026.
The company filed exhibits including a press release and presentation both dated April 23, 2026. The 8-K body does not disclose the content of these materials, only that they are attached as exhibits.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify